Targeting Pro-Fibrotic Macrophages to Reverse Pulmonary Fibrosis with Small RNA Inhibitors
Time: 9:30 am
day: Day Two
Details:
• Exploring the emerging understanding of pro-fibrotic macrophages as key drivers of disease progression
• The concept of small RNA inhibitors and their potential in regulating macrophage activity
• Examining the preclinical evidence for reversing IPF with macrophage reprogramming